Resveratrol in Healthy Adult Participants

Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Chemopreventive Agent Development
Sponsor
National Cancer Institute (NCI)
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00721877
Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it works in healthy adult participants.
Intervention
resveratrol, pharmacological study, laboratory biomarker analysis
Condition
Healthy, no Evidence of Disease
Investigators
Hsiao-Hui (Sherry) Chow

See list of participating sites